Amylin Pharmaceuticals, Inc.'s Statements Are Unsubstantiated and Conclusory Says Eastbourne

SAN RAFAEL, Calif.--(BUSINESS WIRE)--Eastbourne Capital Management, L.L.C. Founder and Portfolio Manager, Richard J. Barry, today provided the following comments in reaction to recent materials filed by Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN):

MORE ON THIS TOPIC